Venlafaxine Hcl



Indications and Reactions:

Role Indications Reactions
Primary
Depression 54.7%
Anxiety 9.9%
Product Used For Unknown Indication 6.7%
Hypertension 4.2%
Major Depression 3.6%
Pain 2.5%
Drug Use For Unknown Indication 2.4%
Schizophrenia 1.8%
Sleep Disorder 1.8%
Bipolar Disorder 1.7%
Post-traumatic Stress Disorder 1.3%
Anxiety Disorder 1.3%
Hot Flush 1.2%
Psychotic Disorder 1.2%
Panic Disorder 1.1%
Schizoaffective Disorder 1.1%
Gastrooesophageal Reflux Disease 1.0%
Drug Exposure During Pregnancy 0.9%
Convulsion 0.8%
Hypothyroidism 0.8%
Drug Ineffective 25.9%
Completed Suicide 8.4%
Vomiting 6.5%
Suicide Attempt 6.1%
Tachycardia 5.4%
Depression 5.2%
Drug Interaction 3.6%
Serotonin Syndrome 3.5%
Suicidal Ideation 3.5%
Tremor 3.5%
Withdrawal Syndrome 3.3%
Death 3.1%
Malaise 3.1%
Somnolence 3.1%
Anxiety 2.7%
Hyponatraemia 2.7%
Nausea 2.7%
Product Substitution Issue 2.7%
Respiratory Arrest 2.7%
Headache 2.5%
Secondary
Drug Use For Unknown Indication 32.9%
Depression 25.3%
Product Used For Unknown Indication 10.7%
Anxiety 8.0%
Hypertension 2.9%
Major Depression 2.7%
Bipolar Disorder 2.7%
Pain 2.1%
Sleep Disorder 1.5%
Psychotic Disorder 1.4%
Bipolar I Disorder 1.3%
Suicide Attempt 1.3%
Ill-defined Disorder 1.2%
Insomnia 1.1%
Completed Suicide 0.9%
Intentional Overdose 0.8%
Diabetes Mellitus 0.8%
Post-traumatic Stress Disorder 0.8%
Hot Flush 0.8%
Panic Attack 0.8%
Completed Suicide 22.8%
Respiratory Arrest 8.8%
Drug Ineffective 7.2%
Death 6.4%
Suicide Attempt 5.7%
Tremor 4.9%
Drug Toxicity 4.6%
Tachycardia 3.8%
Suicidal Ideation 3.7%
Vomiting 3.7%
Poisoning 3.4%
Serotonin Syndrome 3.4%
Cardio-respiratory Arrest 3.3%
Depression 3.1%
Anxiety 2.8%
Overdose 2.8%
Withdrawal Syndrome 2.8%
Weight Increased 2.5%
Nausea 2.1%
Somnolence 2.1%
Concomitant
Drug Use For Unknown Indication 32.0%
Depression 16.8%
Product Used For Unknown Indication 10.4%
Hypertension 5.2%
Rheumatoid Arthritis 5.1%
Pain 5.1%
Anxiety 4.0%
Bipolar Disorder 2.6%
Crohn's Disease 2.4%
Schizophrenia 2.1%
Prophylaxis 1.8%
Insomnia 1.7%
Hiv Infection 1.7%
Multiple Sclerosis 1.6%
Diabetes Mellitus 1.4%
Psychotic Disorder 1.3%
Psoriasis 1.3%
Hepatitis C 1.3%
Asthma 1.2%
Gastrooesophageal Reflux Disease 1.2%
Vomiting 12.3%
Weight Decreased 10.9%
Weight Increased 10.1%
Withdrawal Syndrome 8.0%
Tremor 5.8%
Suicide Attempt 4.6%
Drug Interaction 4.4%
Overdose 4.4%
Death 4.2%
Vision Blurred 4.0%
Pruritus 3.6%
Drug Exposure During Pregnancy 3.4%
Renal Failure Acute 3.4%
White Blood Cell Count Decreased 3.2%
Pulmonary Embolism 3.0%
Somnolence 3.0%
Suicidal Ideation 3.0%
Myocardial Infarction 2.8%
Urinary Tract Infection 2.8%
Vertigo 2.8%
Interacting
Depression 29.0%
Drug Use For Unknown Indication 13.1%
Hypertension 12.9%
Product Used For Unknown Indication 6.6%
Major Depression 5.8%
Type 2 Diabetes Mellitus 5.1%
Sedation 3.4%
Diabetes Mellitus 2.7%
Pain 2.7%
Hypothyroidism 2.4%
Psychotic Disorder 2.4%
Bipolar Disorder 1.9%
Essential Hypertension 1.7%
Glaucoma 1.7%
Hyperlipidaemia 1.7%
Ischaemic Heart Disease Prophylaxis 1.7%
Back Pain 1.5%
Lipids Increased 1.5%
Anxiety 1.2%
Agitation 1.0%
Drug Interaction 16.1%
Urinary Retention 14.3%
Agitation 6.3%
Hyponatraemia 6.3%
Renal Failure Acute 5.4%
Rhabdomyolysis 5.4%
Serotonin Syndrome 5.4%
Traumatic Haematoma 5.4%
Ventricular Extrasystoles 5.4%
Hepatocellular Injury 4.5%
Parkinsonism 4.5%
Loss Of Consciousness 3.6%
Thrombophlebitis 3.6%
Convulsion 2.7%
Hypertensive Crisis 2.7%
Eczema 1.8%
Fatigue 1.8%
Hepatic Failure 1.8%
Hypertension 1.8%
Psychiatric Symptom 1.8%